|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Net amortization of debt securities | |||||
| Net amortization of purchase accounting adjustments and deferred loan fees and costs | |||||
| Origination of loans held for sale | |||||
| Proceeds from loans held for sale | |||||
| Gain on sale of loans | |||||
| Gain on sale of securities | |||||
| Bank-owned life insurance income, net | |||||
| Stock-based compensation, net of tax benefits | |||||
| Depreciation and amortization | |||||
| Loss (gain) on dispositions of premises and equipment | |||||
| Loss (gain) on sale and write-downs of other real estate owned, net | |||||
| Deferred tax (benefit) expense | |||||
| Amortization of core deposit and other intangibles | |||||
| Amortization of investments in variable interest entities | |||||
| Net (increase) decrease in accrued interest receivable | |||||
| Net (increase) decrease in other assets | |||||
| Net (decrease) increase in accrued interest payable | |||||
| Net decrease in operating lease liabilities | |||||
| Net increase (decrease) in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Sales of debt securities, available-for-sale | |||||
| Maturities, prepayments and calls of available-for-sale debt securities | |||||
| Purchases of available-for-sale debt securities | |||||
| Maturities, prepayments and calls of held-to-maturity debt securities | |||||
| Purchases of held-to-maturity debt securities | |||||
| Termination of interest rate swaps | |||||
| Principal collected on loans | |||||
| Loan originations | |||||
| Net change in loans | |||||
| Proceeds from sale of premises and equipment | |||||
| Net additions to premises and equipment | |||||
| Proceeds from sale of other real estate owned | |||||
| Proceeds from redemption of equity securities | |||||
| Purchases of equity securities | |||||
| Proceeds from bank-owned life insurance | |||||
| Investments in variable interest entities | |||||
| Net cash received from acquisitions | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities | |||||
| Net increase (decrease) in deposits | |||||
| Net increase in securities sold under agreements to repurchase | |||||
| Net decrease in short-term Federal Home Loan Bank advances | |||||
| Proceeds from short-term Federal Reserve Bank Term Funding | |||||
| Repayments of short-term Federal Reserve Bank Term Funding | |||||
| Proceeds from long-term Federal Home Loan Bank advances | |||||
| Repayments of long-term Federal Home Loan Bank advances | |||||
| Net (decrease) increase in other borrowed funds | |||||
| Principal payments on finance lease liabilities | |||||
| Cash dividends paid | |||||
| Tax withholding payments for stock-based compensation | |||||
| Proceeds from stock option exercises | |||||
| Net cash (used in) provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash, cash equivalents at beginning of period | |||||
| Cash, cash equivalents at end of period | |||||
| Supplemental Disclosure of Cash Flow Information | |||||
| Cash paid during the period for interest | |||||
| Cash paid during the period for income taxes | |||||
| Supplemental Disclosure of Non-Cash Investing Activities | |||||
| Transfer of debt securities from held-to-maturity to available-for-sale | |||||
| Sale and refinancing of other real estate owned | |||||
| Transfer of loans to other real estate owned | |||||
| Right-of-use assets obtained in exchange for new lease liabilities | |||||
| Equity investments obtained in exchange or delayed equity contributions | |||||
| Dividends declared during the period but not paid | |||||
| Acquisitions | |||||
| Fair value of common stock shares issued | |||||
| Cash consideration | |||||
| Fair value of assets acquired | |||||
| Liabilities assumed | |||||
Loading...